Bosutinib is a drug used to treat a specific type of blood cancer, called Philadelphia chromosome-positive chronic myelogenous leukemia. It is a kinase inhibitor and is available in an oral tablet form. Uses It is usually prescribed for patients who are newly diagnosed with chronic myelogenous leukemia or no longer benefit from other forms of treatment.